Patients With Gaucher's Disease Clinical Trial
— GaucherOfficial title:
Evaluation of Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease.
| Verified date | December 2011 |
| Source | Nantes University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | France: AFSSAPS |
| Study type | Interventional |
The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.
| Status | Completed |
| Enrollment | 10 |
| Est. completion date | July 2011 |
| Est. primary completion date | July 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Adults (age equal or above 18. - Patients with Gaucher 's disease treated in the "Grand Ouest" competence center - patients affiliated to social security - Informed consent signed Exclusion Criteria: - Children (age<18) |
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| France | Nantes Hospital | Nantes | |
| France | CHU of Rennes | Rennes |
| Lead Sponsor | Collaborator |
|---|---|
| Nantes University Hospital |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | To determine the implication of acquired and inherent immunity in the Gaucher's clinical phenotype at moment of blood sampling | No | ||
| Secondary | to find new activity mark for Gaucher's disease by studying macrophagic activation's markers. | No |